This story was originally published by KFF Health News. Montana’s small, independent pharmacies say they’re getting ...

While states continue to bolster cost growth benchmarks, critics argue those programs do not have the regulatory teeth to ...

Determined to pursue research after her father's passing from Parkinson's disease, a student in Hanoi has earned a PhD ...

New faculty member examines how to make sure drugs are getting to their target site and that they’re doing what they're ...

Mark Sears shot a free throw late in the second half that could have cut Alabama's deficit to 10 — a last-gasp effort at a comeback still ...

Over 400 pharmacy professionals urged Texas lawmakers to take action against pharmacy benefit managers (PBM) who are accused ...

Compounding pharmacies have emerged as a crucial player in the evolving landscape of personalized medicine, offering ...

Third-party companies known as pharmacy benefit managers, which administer prescription drug benefits for health insurance plans, employers, and other organizations including governments, are driving ...

The in-person experiment uncovered frequent lack of availability, plus significant stigma around syringe purchases.

The growing prevalence of ultrahigh-cost drugs under development is prompting health systems nationwide to rethink strategies ...

GLP-1s are driving traditional drug spending in the U.S. to unprecedented levels, which now outpaces specialty drug spending for the first time, according to a March 25 report from Evernorth. The ...

The pharmacy benefit landscape is shifting. With rising costs, limited transparency, and rigid structures imposed by legacy pharmacy benefit managers (PBMs), organizations are considering a bold ...